|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn954215088 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
160421s2016 nyu ob 001 0 eng |
| 010 |
|
|
|a 2020677715
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d N$T
|d OCLCF
|d SNK
|d DKU
|d IGB
|d D6H
|d VTS
|d AGLDB
|d AU@
|d G3B
|d S8J
|d S9I
|d STF
|d VLY
|d OCLCO
|d OCLCA
|d OCLCO
|d OCLCQ
|
| 020 |
|
|
|a 9781634853361
|q (e-Book)
|
| 020 |
|
|
|a 1634853369
|
| 020 |
|
|
|z 9781634853224
|q (hardback)
|
| 029 |
1 |
|
|a AU@
|b 000062422213
|
| 035 |
|
|
|a (OCoLC)954215088
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RC280.L9
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 616.99/446
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Primary Central Nervous System Lymphoma (PCNSL) :
|b incidence, management and outcomes /
|c Ryuya Yamanaka, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical,
|c [2016]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 490 |
0 |
|
|a Neurology - Laboratory and Clinical Research Developments
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Description based on print version record; title from PDF title page, viewed (07/14/2020).
|
| 505 |
0 |
|
|a PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): INCIDENCE, MANAGEMENT AND OUTCOMES ; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): INCIDENCE, MANAGEMENT AND OUTCOMES ; CONTENTS ; PREFACE ; I. EPIDEMIOLOGY, PATHOLOGY AND BIOLOGY ; Chapter 1 EPIDEMIOLOGY OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA ; ABSTRACT ; INTRODUCTION ; EPIDEMIOLOGY OF PCNSL; Overall PCNSL Incidence ; PCNSL Incidence Is Higher in Males Than in Females ; PNSCL Incidence Increases with Advancing Age ; Country-Specific Increases in PCNSL Incidence ; Immunodeficiency Is a Risk Factor for PCNSL ; CONCLUSION
|
| 505 |
8 |
|
|a CONCLUSION REFERENCES ; II. DIAGNOSIS ; Chapter 5 DIAGNOSTIC IMAGING OF PRIMARY CENTRAL NERVOUS SYSTEM MALIGNANT LYMPHOMA ; ABSTRACT ; INTRODUCTION; CT AND MRI IN THE DIAGNOSIS OF PCNSL ; FDG PET IN THE DIAGNOSIS OF PCNSL ; Primary Diagnosis and Differentiation from Nontumorous Lesions ; Differentiation from Other Malignant Brain Tumors ; Diagnosis of Atypical PCNSL ; CONCLUSION ; REFERENCES ; Chapter 6 CEREBROSPINAL FLUID INTERLEUKIN-10 (IL-10) AS A DIAGNOSTIC MARKER IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA ; ABSTRACT; INTRODUCTION ; IL-10 IS A USEFUL DIAGNOSTIC MARKER FOR PCNSL
|
| 505 |
8 |
|
|a 1. Case-Control Study 2. Validation Study; CSF IL-10 as a Surrogate Marker for the PCNSL Tumor Status ; Expression and Secretion of IL-10 in PCNSLs ; CSF IL-10 Activates STAT3 Signaling ; Association of CSF IL-10 Levels with Prognosis ; DISCUSSION; Diagnostic Biomarker for PCNSL ; CSF IL-10 and STAT3; CSF IL-10 and Prognosis ; CONCLUSION ; REFERENCES; Chapter 7 GENE EXPRESSION SIGNATURE-BASED PROGNOSTIC RISK SCORE WITH NETWORK STRUCTURE; ABSTRACT ; INTRODUCTION ; METHODS ; Network Clustering ; SSM-PCA; Prognostic Risk Score Based on a Statistical Regression Model ; Evaluation
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Lymphomas
|x Treatment.
|
| 650 |
|
2 |
|a Central Nervous System Neoplasms
|x therapy
|
| 650 |
|
6 |
|a Lymphome
|x Traitement.
|
| 650 |
|
7 |
|a HEALTH & FITNESS / Diseases / General
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Clinical Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Diseases
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Evidence-Based Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Internal Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a Lymphomas
|x Treatment.
|2 fast
|0 (OCoLC)fst01004329
|
| 700 |
1 |
|
|a Yamanaka, Ryuya,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Primary central nervous system lymphoma (PCNSL)
|d New York : Nova Biomedical, [2016]
|z 9781634853224 (hardback)
|w (DLC) 2016939456
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1292499
|z Texto completo
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1292499
|
| 994 |
|
|
|a 92
|b IZTAP
|
